Yüklüyor......
Activation of c-Jun NH(2)-Terminal Kinase (JNK) Is Required for Gemcitabine’s Cytotoxic Effect in Human Lung Cancer H1299 Cells
Although gemcitabine is a potent therapeutic agent in the treatment of human non-small cell lung cancer (NSCLC), resistance to gemcitabine is common. In this study, we investigated the molecular mechanisms involved in acquired gemcitabine resistance against NSCLC cells. Gemcitabine-resistant NSCLC H...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2005
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1351098/ https://ncbi.nlm.nih.gov/pubmed/16307741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.febslet.2005.10.064 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|